Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q2 2026 (June 30)12holders −1
0new positions
1sold out
$23.10avg. 13F price*
At the end of Q2 2026, 12 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 1 sold out. The largest holders were Confluence Investment Management LLC ($1.1M), Rhumbline Advisers ($1.1M) and Sterling Capital Management LLC ($865K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $215K |
All 13F filers, Q1 2026 → Q2 2026: 988 shares bought and 15,894 shares sold, net −14,906 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Confluence Investment Management LLC | 0.02% | Add +1.3% | 47,712 | $1.1M |
| Rhumbline Advisers | 0.00% | Reduce -1.6% | 46,276 | $1.1M |
| Sterling Capital Management LLC | 0.01% | Reduce -7.4% | 37,330 | $865K |
| GAMMA Investing LLC | 0.01% | Reduce -20.9% | 10,828 | $250K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -4.0% | 9,943 | $229K |
| Salomon & Ludwin, LLC | 0.00% | Reduce -8.4% | 1,138 | $25K |
| First Command Advisory Services, Inc. | 0.00% | Add +292.6% | 479 | $11K |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0.00% | No change | 256 | $6K |
| Hantz Financial Services, Inc. | 0.00% | No change | 211 | $5K |
| Ancora Advisors LLC | 0.00% | Reduce -88.6% | 122 | $3K |
| IMA Advisory Services, Inc. | 0.00% | Add +59.4% | 51 | $1K |
| Richardson Financial Services Inc. | 0.00% | No change | 13 | $300 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.